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Abstract 
This paper aims at emphasizing the difficulty in assessing preoperatively the diagnosis of 
solid masses of the pancreas whatever the initial clinical presentation may be. We 
illustrate our purpose describing consecutive cases of pancreatic masses of the pancreas 
we recently had and who were followed according to the internal guidelines of 
investigation of our referral hospital. Whereas malignant tumors of the pancreas 
represent the vast majority of solid tumors of the pancreas, other diagnoses must be 
evoked. We report three cases of pancreatic solid masses that were explored by 
endoscopic ultrasonography coupled with fine needle aspiration, a method universally 
considered to be both reliable and accurate but which failed to assess definitive 
diagnosis due to both cytological pitfalls and sampling error. 
 
Introduction 
Ductal pancreatic adenocarcinoma is by far the first diagnosis to evoke when dealing 
with a solid mass of the pancreas as its frequency reaches 85–95% [1]. However, other 
diagnoses must be considered such as endocrine tumors which may account for 1–3% of 
pancreatic tumors, solid and pseudopapillary tumor or benign pseudotumoral lesions 
such as autoimmune pancreatitis [2, 3]. Even rarer are metastatic tumors to the pancreas 
or mesenchymal and hematopoietic cancers arising in the pancreas (liposarcoma, 
leiomyosarcoma, fibrosarcoma, and lymphoma) [4]. These differential diagnoses depend 
on clinical presentation: solid and pseudopapillary tumors, for example, although rare, are 
frequently evoked in women of child-bearing age [5].  
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To avoid surgery when not indicated, endoscopic ultrasonography (EUS) coupled with 
fine needle aspiration (FNA) has been universally recognized as efficient and safe [6]. 
Indeed, EUS-FNA is feasible in 90–95% of all pancreatic masses and its performance in 
collecting adequate tissue to get a final diagnosis is close to 80–95% [6–8]. However, 
sampling or interpretation errors can lead to misdiagnosis. 
We present three cases where clinical presentation, sampling error or cytologic 
interpretation led to a wrong preoperative diagnosis. 
Case 1 
A 17-year-old otherwise healthy woman presented with a 2-month history of recurrent epigastric 
pain without nausea nor vomiting. Physical examination was unremarkable. C-reactive protein was 
within normal range. Her liver tests were normal whereas serum lipase was increased at 609 U/l (normal 
114–329). Serum IgG4 was within normal range. Abdominal ultrasound was normal. Computed 
tomography scan showed a 4 × 2 cm hypodense mass of the pancreatic tail only seen during the arterial 
phase of the scan (fig. 1a). She was referred to us for EUS-FNA. EUS demonstrated a hypoechoic 
heterogeneous mass of the pancreatic tail (fig. 1b). FNA brought back a very scant material consisting of 
few monotonous oval cells with round to oval nuclei and moderate cytoplasm. In addition, hyaline 
globules were present and led the cytopathologist, in this particular clinical setting, to assess the 
diagnosis of solid and pseudopapillary tumor of the pancreas, previously referred to as papillary cystic 
tumor and papillary cystic neoplasm. The patient was then referred to the surgeon for a left 
pancreatectomy. A partial pancreatectomy was realized. On final macroscopic examination, the 
pancreas appeared diffusely enlarged, without any visible mass. On histological examination, pancreatic 
parenchyma was modified by abundant fibrosis accompanied by a florid inflammatory infiltrate. This 
infiltrate set predominantly around the pancreatic ducts and was mainly composed of plasmocytes. The 
final histological diagnosis was autoimmune pancreatitis. The postoperative period was characterized by 
recurrent abdominal pain and persistence of increased lipase. Steroids were then introduced for 
2 months with a complete absence of pain and normalization of serum lipase. 
Case 2 
A 58-year-old woman without any relevant past medical history presented with a 2-month period of 
recurrent abdominal pain associated with significant weight loss of 6 kg. There was no history of 
tobacco or alcohol use. Laboratory investigation was unremarkable. Serum IgG4 was within normal 
range. CT scan showed a large hypodense mass of the pancreatic body, 50 mm in size (fig. 2a). EUS 
demonstrated a large 45 mm hypoechoic mass of the uncinatus process, very well delineated with a 
hyperechoic wall (fig. 2b). PET-CT scan identified a large hypermetabolic spot within the head of the 
pancreas corresponding to the tumor seen at CT (fig. 2c). EUS-FNA was performed, but it was very 
poorly cellular and was mainly composed of gastrointestinal cells and thus not conclusive. The patient 
was sent to the surgeon with the putative diagnosis of solid and pseudopapillary tumor of the pancreas 
based on her history and imaging studies. A duodenopancreatectomy was performed. A 3.5 cm mass 
was present in the head of the pancreas, mainly solid but with a central necroticohemorragic aspect. 
This tumor was delineated by a dense fibrous capsule. The final histological diagnosis was 
pancreatoblastoma due to the presence of both endocrine and acinar cells associated with squamoid 
nest. The immunohistochemical study showed a predominant endocrine component and a peculiar 
staining for β-catenin, centred on squamoid nests as it has been previously described [9]. Seven lymph 
nodes were retrieved, all negative. No adjuvant treatment was initiated. 
Case 3 
A 67-year-old man with a past history of alcohol abuse presented with a first attack of acute 
pancreatitis characterized by abdominal pain associated with a serum lipase elevated at 785 U/l. The 
patient was a heavy smoker. Physical examination upon admission revealed moderate epigastric 
tenderness that disappeared within 6 h after admission. CRP was within normal range. His liver tests 
were normal. CT scan showed a normal gallbladder without stone and a focal mass of 2 cm in the tail of 
the pancreas (fig. 3a). EUS identified irregular main duct and side branch duct with hyperechoic and  
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thickened wall, pseudolobular aspect of the pancreatic parenchyma with hyperechoic strands and a solid 
hyperechoic mass of 25 mm in size located in the tail of the pancreas (fig. 3b) and in close contact with 
the splenic vein. Hormones including insulin, glucagon, vasointestinal peptide, chromogranin and 
serotonin were within normal range. Octreoscan identified a hyperactive spot 5 and 24 h after tracer 
injection in the tail of the pancreas highly suggestive of a neuroendocrine tumor (fig. 3c). EUS-FNA was 
performed and retrieved hemorrhagic material with scattered lymphocytes and was thus considered as 
inconclusive. Left pancreatectomy with spleen preservation was performed. A 2 cm well-delineated 
brown mass similar to spleen was present within the pancreatic parenchyma. Histology confirmed the 
splenic nature of the lesion and then assessed a diagnosis of intrapancreatic accessory spleen. 
Discussion 
There are many different types of tumors that can develop in the pancreas. 
Approximately 85–90% of solid masses are adenocarcinomas of the pancreas [10]. The 
remaining 10–15% correspond, most of the time, to less aggressive types of tumors which 
are often curable [11]. We report three cases of pancreatic solid masses that were initially 
explored by CT scan and then by EUS-FNA, a method universally considered to be both 
reliable and accurate [12]. In our cases, however, EUS-FNA failed to assess a definitive 
diagnosis due to both cytological pitfalls and sampling error. 
In the first case, EUS-FNA brought relatively bland-looking cells with peculiar hyaline 
globules, which in retrospect corresponded either to ductular or gastrointestinal cells as 
has been previously reported [13–15]. The hyaline globules were probably due to 
epithelial degeneration. Smears lacked the cellular inflammatory stromal fragments highly 
suggestive of autoimmune pancreatitis and were also completely devoid of inflammatory 
cells [13]. However, low sensitivity of EUS-FNA in a context of autoimmune pancreatitis 
is well described [13–15]. EUS studies have shown that EUS-trucut biopsy could serve as a 
rescue technique in cases of autoimmune pancreatitis lacking typical findings [16], a 
feature already reported for EUS-FNA [17] but associated with a higher rate of 
complications. 
In the second case, EUS-FNA was unable to bring enough material. For definitive 
diagnosis, expert consultation was required [18]. Pancreatoblastomas are indeed rare in 
adults, and this one presented a peculiar morphological aspect. The endocrine component 
was heavily predominant and the squamoid nests were barely visible. That is why the 
diagnosis of endocrine tumor was first evoked. However, immunostaining for β-catenin 
was typical with an intense nuclear staining in squamoid nests and a membranous 
staining in endocrine and acinar component. Even though β-catenin has been rarely 
described as having nuclear staining in pancreatic endocrine tumors, it presents a 
heterogeneous distribution very different from the systematized staining obtained here 
[19]. 
In the third case, the clinical and biological data suggesting a nonfunctional endocrine 
tumor were strongly supported by the octreoscan results. EUS-FNA retrieved a lot of red 
cells coupled to lymphocytes and no other cell type, a feature that has to be confronted to 
the final diagnosis of intrapancreatic accessory spleen, a rare benign condition [20]. A 
small radiological series showed that magnetic resonance imaging may be the diagnostic 
test to use in such a suspicion [21]. Indeed, the discovery of a well-marginated, rounded 
mass in the distal aspect of the tail of the pancreas with signal intensity features of the 
spleen on all precontrast and postgadolinium sequences suggests the diagnosis of 
intrapancreatic accessory spleen [21].  
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In these three cases, EUS-FNA failed to make the right preoperative diagnosis for 
different reasons. In the first case, the clinical presentation (a tumor located in the 
pancreatic tail in a young woman) forced the pathologist to overinterpret contaminant as 
tumor cells. The final diagnosis of autoimmune pancreatitis was however quite surprising 
in such a clinical context as it is described to develop around the age of 50. In the second 
case, the clinical suspicion of solid and pseudopapillary tumor was high enough to 
undertake surgery despite the inconclusive cytological examination. Here again, the 
diagnosis of pancreatoblastoma in an adult was so rare that it was not even evoked 
preoperatively. In the third case, the lesion was indeed correctly sampled as FNA brought 
both blood and lymphocytes coming from the spleen. However, as this diagnosis was not 
even suspected clinically and radiologically, this was not even taken into consideration. 
EUS-FNA is known to need clinical correlation to be interpreted, but the initial clinical 
presentation may bias the cytological or imaging results. These three observations 
emphasize the importance of considering other diagnoses before sending the patient to 
the surgeon for a procedure that carries a substantial risk of complications and mortality. 
 
 
 
 
 
Fig. 1. a CT scan showing a 4 × 2 cm hypodense mass of the pancreatic tail. b EUS showing a 
heterogenous hypoechoic mass of the tail of the pancreas using a sectorial endoscope at the time of 
FNA. 
 
 
 
Fig. 2. a CT scan with a large corporeal hypodense mass of the pancreas with fine delineated 
hyperechoic wall. b The mass seen at EUS was hypoechoic with a strong heterogenous content. 
c PET-CT demonstrated a huge hypermetabolic state of the pancreatic mass. 
 
 
  
Case Rep Gastroenterol 2009;3:389–394 
DOI: 10.1159/000255401 
Published online: November 21, 2009  © 2009 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
393
Fig. 3. a CT showed a well-delineated mass of the pancreatic tail without upstream ductular dilatation. 
b A small homogenous mass of the pancreas was demonstrated by EUS at the time of FNA. Note that 
the mass was very well delineated. c Octreoscan identified a hyperintense spot located in the tail of the 
pancreas when compared to the spleen. 
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